AZN - AZN and SGH among premarket losers March, 29 2019 09:18 AM AstraZeneca PLC ENDRA Life Sciences (NASDAQ:NDRA) -28% on reporting initial findings on first human TAEUS feasibility study of liver fat.More news on: ENDRA Life Sciences Inc., Chiasma, Inc., SMART Global Holdings, Inc., Stocks on the move, Read more ...